ZA995489B - Microbial biotransformation. - Google Patents

Microbial biotransformation.

Info

Publication number
ZA995489B
ZA995489B ZA9905489A ZA995489A ZA995489B ZA 995489 B ZA995489 B ZA 995489B ZA 9905489 A ZA9905489 A ZA 9905489A ZA 995489 A ZA995489 A ZA 995489A ZA 995489 B ZA995489 B ZA 995489B
Authority
ZA
South Africa
Prior art keywords
microbial biotransformation
biotransformation
microbial
Prior art date
Application number
ZA9905489A
Other languages
English (en)
Inventor
Susan Jane Truesdell
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA995489B publication Critical patent/ZA995489B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9905489A 1998-08-28 1999-08-26 Microbial biotransformation. ZA995489B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9825598P 1998-08-28 1998-08-28

Publications (1)

Publication Number Publication Date
ZA995489B true ZA995489B (en) 2001-02-26

Family

ID=22268411

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9905489A ZA995489B (en) 1998-08-28 1999-08-26 Microbial biotransformation.

Country Status (26)

Country Link
EP (1) EP0989187B1 (pt)
JP (2) JP3103539B2 (pt)
KR (1) KR100338917B1 (pt)
CN (2) CN1177935C (pt)
AR (1) AR016505A1 (pt)
AT (1) ATE380251T1 (pt)
AU (1) AU749873B2 (pt)
BR (1) BR9903971A (pt)
CA (1) CA2280994C (pt)
CY (1) CY1107291T1 (pt)
CZ (1) CZ298476B6 (pt)
DE (1) DE69937662T2 (pt)
DK (1) DK0989187T3 (pt)
ES (1) ES2297913T3 (pt)
HK (2) HK1028068A1 (pt)
HU (1) HU226215B1 (pt)
ID (1) ID23459A (pt)
IL (1) IL131613A0 (pt)
IN (1) IN191812B (pt)
PL (1) PL197322B1 (pt)
PT (1) PT989187E (pt)
RU (1) RU2203954C2 (pt)
TR (1) TR199902097A2 (pt)
TW (1) TWI225096B (pt)
YU (1) YU40599A (pt)
ZA (1) ZA995489B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124616T2 (de) 2000-05-08 2007-09-13 Pfizer Products Inc., Groton Enzymatische Spaltung von selektiven Modulatoren des Östrogenrezeptors

Also Published As

Publication number Publication date
AU749873B2 (en) 2002-07-04
HK1068373A1 (en) 2005-04-29
HK1028068A1 (en) 2001-02-02
PL335149A1 (en) 2000-03-13
CN1177935C (zh) 2004-12-01
JP3103539B2 (ja) 2000-10-30
ID23459A (id) 2000-04-27
CY1107291T1 (el) 2012-11-21
BR9903971A (pt) 2000-10-17
PL197322B1 (pl) 2008-03-31
ES2297913T3 (es) 2008-05-01
CA2280994A1 (en) 2000-02-28
TR199902097A2 (xx) 2000-03-21
HU9902903D0 (en) 1999-10-28
AU4482599A (en) 2000-03-16
CA2280994C (en) 2002-12-24
HUP9902903A2 (en) 2000-07-28
EP0989187A3 (en) 2001-06-13
DK0989187T3 (da) 2008-01-28
JP2000279189A (ja) 2000-10-10
KR100338917B1 (ko) 2002-05-30
CN1259577A (zh) 2000-07-12
EP0989187A2 (en) 2000-03-29
JP2000069989A (ja) 2000-03-07
RU2203954C2 (ru) 2003-05-10
AR016505A1 (es) 2001-07-04
CZ308099A3 (cs) 2000-03-15
IN191812B (pt) 2004-01-03
ATE380251T1 (de) 2007-12-15
TWI225096B (en) 2004-12-11
EP0989187B1 (en) 2007-12-05
YU40599A (sh) 2002-03-18
HUP9902903A3 (en) 2002-09-30
CN1271209C (zh) 2006-08-23
DE69937662T2 (de) 2008-04-10
PT989187E (pt) 2008-02-21
CZ298476B6 (cs) 2007-10-17
DE69937662D1 (de) 2008-01-17
KR20000017603A (ko) 2000-03-25
CN1552883A (zh) 2004-12-08
IL131613A0 (en) 2001-01-28
HU226215B1 (en) 2008-06-30

Similar Documents

Publication Publication Date Title
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA99254B (en) Benzosulfone derivatives.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
ZA991272B (en) Novel thiobenzamides.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
HK1042999A1 (en) Wdm-channel equalizer.
ZA992443B (en) Hydroxy-methyl-hexanones.
MXPA01002327A (es) Polipepetido de nissseria spp, secuencia, de acidos nucleicos y usos de estos.
ZA991550B (en) Cyclohexanediole derivatives.
ZA993123B (en) Trisresorcinyltriazines.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
MXPA01011670A (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas sodc relacionadso y sus usos.
MXPA01011570A (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con peptido h de membrana externa.
HK1021879A1 (en) Carrying case.
MXPA01011669A (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con fige y sus usos.
ZA995489B (en) Microbial biotransformation.
HK1028588A1 (en) Case.
IL153534A0 (en) Microbial biotransformation
HK1031254A1 (en) Tachogragh.
ZA99925B (en) Composition.
ZA993401B (en) Formamidinesulfinic-acid blends II.